Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7541034
SERIAL NO

09381497

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

exotoxin or a detectable label. The invention provides diagnostic methods, and means to inhibit the growth of malignant B cells.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNITED STATES OF AMERICAN AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICESOFFICE OF TECHNOLOGY TRANSFER 6011 EXECUTIVE BLVD SUITE 325 ROCKVILLE MD 20852

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fitzgerald, David J Rockville, US 55 830
Kreitman, Robert Potomac, US 5 103
Mansfield, Elizabeth Bethesda, US 2 57
Pastan, Ira Potomac, US 66 1404

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation